Remix Therapeutics
MA - WatertownBiotechnology
Focus: Remix Therapeutics is a public biotech company focused on small molecule therapies that reprogram RNA processing, with a novel approach to gene therapy. The company is early-stage with a minimal commercial footprint and operates from Watertown, MA.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2
Should You Work at Remix Therapeutics?
AI assessmentHigh-risk, high-reward early-stage biotech suitable only for scientists/strategists comfortable with platform bet uncertainty and minimal near-term job security.
Why Work Here
- Access to cutting-edge RNA processing science with proprietary platform technology in an emerging field
- Early-stage opportunity to shape company culture and processes at a recently public biotech
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
REM-422
Myelodysplastic SyndromesClinical Trials (1)
NCT06297941Study of REM-422 in Patients With AML or Higher Risk MDS
Phase 1Help build intelligence for Remix Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.